Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX) - Zolmax
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX) - Daily Political
Zacks Research Has Positive Outlook for Novavax Q2 Earnings - Stock Observer
Why Novavax (NVAX) Stock Is Trading Up Today
Novavax (NASDAQ:NVAX) Stock Price Up 11.6% - What's Next? - Daily Political
The Bull Case For Novavax (NVAX) Could Change Following Shah Capital's Activist Governance Challenge - Learn Why
Assessing Novavax (NVAX) Valuation As Shah Capital Challenges Leadership And Sanofi Partnership
GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know
The Top 5 Analyst Questions From Novavax's Q1 Earnings Call
Are Novavax's (NVAX) Activist Pressure and Partnership Pivot Quietly Rewriting Its Investment Narrative?
Israel to offer non-mRNA coronavirus vaccine
Novavax Inc at Bank of America Global Healthcare Conference Transcript
Novavax (NVAX) Is Up 25.9% After Pfizer Matrix-M Deal And Q1 Beat On Expectations - What's Changed
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Novavax Stock Is Red Hot but the Smart Money Is Slamming on the Brakes
Novavax (NVAX) Valuation Check After Pfizer Licensing Deal And Partnership-Led Earnings Beat
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK), Novavax (NVAX) and Airsculpt Technologies (AIRS)
Traders Buy High Volume of Call Options on Novavax (NASDAQ:NVAX)
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Analysts
Novavax (NASDAQ:NVAX) Stock Price Expected to Rise, TD Cowen Analyst Says - Daily Political
Novavax Surpasses Revenue Expectations in Q1, Surges Over 14%, ETPharma
Q1 2026 Novavax Inc Earnings Call Transcript
Novavax (NASDAQ:NVAX) Issues Quarterly Earnings Results
Why Novavax (NVAX) Is Up 17.4% After Q1 2026 Revenue Plunge And Profit Swing To Loss
Novavax Q1 Earnings Call Highlights
Novavax (NASDAQ:NVAX) Price Target Raised to $9.00 at TD Cowen
Novavax (NASDAQ:NVAX) Shares Up 12.9% After Strong Earnings
Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars
Novavax beats first-quarter revenue estimates on strength in vaccine deals
Is It Time To Reconsider Novavax (NVAX) After A 95% Five Year Share Price Fall
Assessing Novavax (NVAX) Valuation As Licensing Pivot And Key Vaccine Readout Approach
Novavax (NVAX) to Release Earnings on Wednesday
A Look At Novavax (NVAX) Valuation As It Shifts To Licensing And Awaits Combo Vaccine Data
Is Novavax, Inc. (NVAX) A Good Stock To Buy Now?
Novavax to Report First Quarter 2026 Financial Results on Ma
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
